Impact of CO2 on Cerebral Blood Flow in Infants Less Than 6 Months During General Anaesthesia

NCT ID: NCT03567031

Last Updated: 2019-10-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-11-27

Study Completion Date

2019-03-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study aims at assessing cerebral blood flow variations following expired CO2 variations in anaesthetized infants less than 6 months, during a routine general anesthesia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study aims at assessing cerebral blood flow (measured with Near-Infrared Reflectance Spectroscopy - NIRS - and transcranial Doppler - DTC) variations following end-tidal expired CO2 variations in anaesthetized infants less than 6 months, during a routine general anesthesia performed according to standards of care.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anesthesia, General Infant

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Cerebral blood flow is measured in each patient at 3 different, controlled levels of end-tidal CO2
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Patient is under general anesthesia

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Main Arm

In each patient, under ongoing standard general anesthesia in a stable state, EtCO2 is manually modified to reach predefined values, and after waiting until cerebral blood flow has reached steady state, NIRS and DTC values are noted.

Group Type EXPERIMENTAL

EtCO2 modification

Intervention Type PROCEDURE

Controlled modification of EtCO2 through modification of ventilation parameters under general anesthesia without spontaneous breathing

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

EtCO2 modification

Controlled modification of EtCO2 through modification of ventilation parameters under general anesthesia without spontaneous breathing

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age \< or = 6 months
* ASA class \< or = 3
* General anesthesia required for surgery

Exclusion Criteria

* No parental consent
* Emergency surgery
* Preexisting neurological condition
* Hemodynamic instability
* Preexisting hypoxemia and/or hypercapnia
* Laparoscopy or thoracoscopy, if expected EtCO2 level achieving would require unsafe ventilation parameters
Maximum Eligible Age

6 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

St. Justine's Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bruno Greff

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bruno Greff, MD

Role: PRINCIPAL_INVESTIGATOR

Sainte Justine's Hospital

Ossam Rhondali, MD

Role: STUDY_DIRECTOR

Sainte Justine's Hospital

Jose Luis Martinez, MD

Role: STUDY_CHAIR

Sainte Justine's Hospital

Chantal Crochetière, MD

Role: STUDY_CHAIR

Sainte Justine's Hospital

Valérie Gaspard, MD

Role: STUDY_CHAIR

Sainte Justine's Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sainte Justine's Hospital

Montreal, Quebec, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

#2017-1309

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.